Next Generation News and Research

RSS

CSL Behring launches next generation HeliTrax System for Apple's devices

CSL Behring announced today the availability of the next generation HeliTrax System as part of a specially designed software platform for Apple's iPhone, iPod touch, or iPad devices. This enhanced system is designed to improve therapy management for people with hemophilia A who use CSL Behring's recombinant factor VIII (rFVIII).

2 Dec 2010

'Margaret Foti Award' for best thesis in translational oncology established

The American Association for Cancer Research, in cooperation with the University of Catania Ph.D. Oncology Program and the Italian League Against Cancer of Catania, announces the establishment of the "Margaret Foti Award" for the best thesis in translational oncology. The first awards will be given on Dec. 2, 2010, in Catania, Italy.

1 Dec 2010

Roche NimbleGen announces NewGene as first certified service provider in the UK

Roche NimbleGen announces that Newcastle-based genomic services provider NewGene Ltd. has officially become a Certified Service Provider (CSP) for NimbleGen Sequence Capture. They will provide services for NimbleGen Sequence Capture Arrays with sequencing on the Genome Sequencer FLX System from 454 Life Sciences, a Roche Company.

1 Dec 2010

Spinal Modulation's Dorsal Root Ganglion Stimulation Pilot Clinical Trial results to be presented at 14th NANS

SPINAL MODULATION, Inc., a privately held medical device company focused on developing devices to treat chronic pain, today announced that the results of its prospective, multicenter Dorsal Root Ganglion (DRG) Stimulation Clinical Trial will be presented by David Caraway, MD, PhD, Timothy Deer, MD and Robert Levy, MD, PhD at the 14th Annual North American Neuromodulation Society (NANS) meeting.

30 Nov 2010

Total Immersion adds Vantage Surgical Systems to North American AR Partner network

Total Immersion, the global leader in augmented reality (AR), today announced the addition of Vantage Surgical Systems as a Certified D'Fusion Value Added Reseller to its North American Partner network, the world's largest network dedicated to AR.

30 Nov 2010

Toshiba to showcase Infinix VF-i bi-plane system at RSNA annual meeting

When imaging patients in the cath lab, it is critical that the vascular X-ray system provides clinicians unprecedented access without restricting image angles. Designed to increase flexibility and diagnostic capabilities, especially in neuro and pediatric imaging, Toshiba America Medical Systems, Inc. will showcase the Infinix VF-i bi-plane vascular X-ray system with dual 12" x 12" mid-sized flat panel detectors at this year's Radiological Society of North America (RSNA) annual meeting in Chicago.

30 Nov 2010

Philips launches new Ingenuity CT platform for optimizing low-dose imaging

At the 96th annual meeting of the Radiological Society of North America (RSNA) in Chicago, Royal Philips Electronics announced today the new Philips Ingenuity CT (computed tomography) platform, an innovative technology that will help redefine low dose imaging.

From Philips Healthcare 30 Nov 2010

Universal microfluidics connector could find broad use in compact medical devices

Biomedical engineers at UC Davis have developed a plug-in interface for the microfluidic chips that will form the basis of the next generation of compact medical devices. They hope that the "fit to flow" interface will become as ubiquitous as the USB interface for computer peripherals.

30 Nov 2010

GE announces 510k clearance for wireless, digital X-ray detector at 96th RSNA

GE Healthcare announced today the 510k clearance of its next generation wireless, digital X-ray detector at the 96TH annual meeting of the Radiological Society of North America (RSNA) in Chicago. GE's FlashPad is a reliable, long-term investment for future Radiography and Fluoroscopy systems, compatible with a variety of GE X-ray products today and is the only wireless digital detector capable of supporting advanced applications.

30 Nov 2010

Life Technologies launches Qubit 2.0 Fluorometer for molecular biology research

Life Technologies Corporation, a provider of innovative life science solutions, today announced the launch of its next-generation Qubit® 2.0 Fluorometer specifically for molecular biology researchers who work with precious samples and perform applications that require a large financial or time investment. The new system quantitates DNA, RNA and protein with accuracy, sensitivity, speed and ease-of-use.

29 Nov 2010

E. coli host bacterium produces antibiotic erythromycin A

Researchers at Tufts University School of Engineering have reported the first successful production of the antibiotic erythromycin A, and two variations, using E. coli as the production host.

24 Nov 2010

Dr. Yves DeClerck honored as first recipient of Richard Call Family Endowed Chair

Yves A. DeClerck, MD, professor of Pediatrics, Biochemistry and Molecular Biology at the Keck School of Medicine of the University of Southern California, has been inducted as the inaugural holder of the Richard Call Family Endowed Chair in Pediatric Research Innovation.

24 Nov 2010

Medicalis to showcase Radiology Collaborative Workflow Solutions at 96th RSNA

Medicalis today announced the commercialization of its next generation Radiology Collaborative Workflow Solutions™ offering providers a sophisticated technology platform to enhance productivity and ensure the delivery of measureable high-quality radiology care. For the first time, the company will showcase its three groundbreaking Collaborative Workflow Solutions at the 96th annual meeting of the Radiological Society of North America (RSNA), Nov. 28 – Dec. 2, in Chicago (Booth 4050).

23 Nov 2010

Mother’s high-fat diet alters fetal genes that regulate circadian rhythm: Study

The link between sleeping and obesity is drawn tighter as a new research published online in the FASEB Journal study shows that what your mother ate when she was pregnant may make you obese or overweight by altering the function of genes (epigenetic changes) that regulate circadian rhythm.

23 Nov 2010

Confidisc introduces new anti-illegal drug syringe

ConfiDisc's anti-illegal drug syringe is an integral part of its syringe injection system. The disc, which is attached to the hub of a syringe device, acts as a physical barrier.

22 Nov 2010

ImmunGene awarded $244,479 therapeutic discovery project grant under PPACA 2010

ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics with numerous anti-cancer functions built into a single therapy, announced today that it has received a $244,479 grant under The Patient Protection and Affordable Care Act of 2010 (PPACA). The grant was related to the development of ImmunGene's technology which is based on antibody-cytokine fusions that have demonstrated targeted toxicity and added tumor benefits.

22 Nov 2010

Eastern Virginia professor says average doctor may be toting new pocket-sized ultrasound machine

Since the Civil War, the stethoscope has been a standard tool of the trade for physicians. Soon, the average doctor may be toting another valuable diagnostic tool: a pocket-sized ultrasound machine.

20 Nov 2010

Removal of tobacco displays changes young people's attitude to smoking

Putting tobacco out of sight in shops not only changes young people's attitude to smoking but doesn't result in retailers losing money - according to new research published in Tobacco Control today (Friday).

20 Nov 2010

Boston Scientific's CRT-Ds, ICDs receive CE Mark approval

Boston Scientific Corporation today announced CE Mark approval of its INCEPTA, ENERGEN and PUNCTUA cardiac resynchronization therapy defibrillators and implantable cardioverter defibrillators.

19 Nov 2010

Elorac announces results of Phase III CPO solution studies for acne at Healthcare Conference in New York

Elorac, Inc., a rapidly growing specialty pharmaceutical company focused on the treatment of dermatological disorders, announced results of two Phase III studies of its patented Carbamide Peroxide (CPO) solution for the treatment of inflammatory acne vulgaris and rosacea at the Lazard Capital Markets 7th Annual Healthcare Conference in New York.

19 Nov 2010